|Andy Evans is professor of breast imaging at Dundee University. He is a leading authority on shear-wave elastography of the breast. Other fields of expertise include breast cancer screening and ductal carcinoma in situ. He is a past chairman of the British society of Breast Radiology, a member of the scientific committee of the European Society of Breast Imaging and a member of Breast Imaging subcommittee of the European Congress of Radiology. His research outputs include over 160 peer reviewed publications, 17 book chapters and 3 books. He also plays the French horn and is a successful composer of classical music.|
|Cecily Quinn MB (hons), MD, FRCPI, FRCPath, FFPath is Clinical Professor at University College Dublin School of Medicine and Medical Sciences. Consultant Histopathologist at St. Vincent’s University Hospital, Dublin and Lead Histopathologist at the Merrion Unit of the Irish National Breast Screening Programme. Professor Quinn graduated from University College Galway in 1982. She trained at the Hammersmith Hospital and Royal Postgraduate Medical School in London and was Consultant Breast Histopathologist at The General Infirmary at Leeds and Honorary Senior Lecturer at the University of Leeds until 1999 when she took up her present post. Professor Quinn is Chair of the European Working Group for Breast Screening Pathology and Clinical Vice-Chair of the European Commission Initiative on Breast Cancer (ECIBC) project. She is a member of the Irish National Quality Assurance Breast Screening Committee and represents Ireland on the UK NHS Breast External Quality Assurance Histopathology Committee. Her main research interests are the pathology of early neoplastic lesions of the breast, and prognostic and predictive markers in invasive breast disease. She has published extensively in the field of breast pathology. She is a member of the International Editorial Advisory Board of Histopathology and served as a committee member of the Pathological Society of Great Britain and Ireland from 2012 to 2015. Professor Quinn was the RCPI National Specialty Director in Histopathology from 2012 to 2016 and represented Histopathology on the RCPI Imrie and Keane review committees.|
Dr Eddie Gibson is a Consultant Radiologist at Antrim Area Hospital, N Ireland. Born in Fermanagh, after schooling he moved to England and qualified as a Doctor at Liverpool University in 2001. After moving back to N Ireland in 2006 Dr Gibson completed his Radiology training in 2009 and then completed a Fellowship in Breast Imaging in Auckland NZ before returning to Antrim Hospital in 2010.
In 2014 Dr Gibson was appointed QA Lead Radiologist for the NI Breast Screening programme. He is also the Lead Radiologist for the NI Higher Risk surveillance screening programme.
|Dr. Elizabeth Morris is Chief of the Breast Imaging Service at Memorial Sloan Kettering Cancer Center (MSKCC) and Professor of Radiology at Weill Cornell Medical College and the Larry Norton Endowed Chair. She is a fellow of the American College of Radiology (ACR), Society of Breast Imaging (SBI) and International Society of MR in Medicine (ISMRM). She currently serves as President of the SBI. Dr. Morris graduated summa cum laude from the University of California Davis and received her medical degree from the University of California, San Francisco (UCSF). She completed her residency at Cornell University Medical College and breast imaging fellow ship at MSKCC. Her research focus is on how best to use newer techniques such as MRI for early breast cancer detection and to improve the workup of breast lesions. In collaboration with her colleagues, she has written over 130 papers, chapters, and books about breast disease with an emphasis on the use of MRI. She has lectured widely both nationally and internationally at over 300 conferences. Currently, she chairs the MR section of the ACR BIRADS® Lexicon. She has authored a book “Breast MRI: Diagnosis & Intervention.” Her recent research efforts have involved looking at imaging biomarkers to assess risk and treatment response.|
|Emma did her radiology training in the Mater Hospital in Dublin and will become a Breast Imaging Fellow in the Mater Hospital at the time of the conference.|
|Dr. Eugene Teoh is a CRUK Cancer Imaging Centre clinical research fellow from the University of Oxford and a final year radiology registrar, sub specialising in radionuclide radiology. He is in the penultimate month of his PhD investigating the use of fluciclovine in cancer imaging, which has encompassed preclinical work in Prof. Adrian Harris’ lab at the Weatherall Institute of Molecular Medicine, and running an ongoing trial as clinical co-investigator to evaluate its use in characterising breast cancer biology.|
Iain Lyburn is a Consultant Radiologist with an interest in Oncologic and Functional Imaging, appointed to Gloucestershire Hospitals NHS Foundation Trust in 2002. He has been Clinical Director of Gloucestershire NHS Breast Screening since 2004 and is also currently Medical Director & Professor of Medical Imaging at the medical charity Cobalt Health, Cheltenham. He is a member of The National Cancer Research Institute (NCRI) Breast Translational and Imaging Subgroup, Public Health England (PHE) National Advisory Committee on Breast Screening and The Administration of Radioactive Substances Act Committee (ARSAC). He has co-authored over 70 peer-reviewed articles, 1 textbook and 5 book chapters.
Iain is married with 2 children and is a keen amateur photographer, gardener and distance runner.
|Mr Harvey is a Consultant Oncoplastic Breast Surgeon at the Nightingale & Prevent Breast Cancer Prevention Centre in Manchester.
He is a member of the Association of Breast Surgery Academic & Research Committee promoting breast and breast surgical research. He is a Medical Advisor for the Prevent Breast Cancer Charity - the only breast cancer charity dedicated to breast cancer prevention. Mr Harvey is author of the Oxford Handbook of Breast Disease Management and is an Honorary Senior Lecturer at the University of Manchester. He has research interests in the areas of breast reconstruction outcomes and innovations in breast cancer surgery including the Magseed magnetic seed localisation device. Mr Harvey is the Chief Investigator of studies using the Magseed localisation device in mastectomy and lumpectomy patients in multi-site studies in the UK.
I qualified (MBBS) at Charing Cross and Westminster Medical School in 1987 having taken an intercalated BSc in Anatomy. In 1989, I came to Bristol for a surgical rotation, and was awarded Fellowship of the Royal College of Surgeons of London (FRCS) in 1992. In August 2014, I was inspired by Christiane Kuhl’s published work on FAST MRI to begin to develop a research proposal investigating the potential uses for this technique in a screening context. In 2015 I presented my initial plans for this proposal to the BSBR, and to the Breast and Screening, Prevention and Early Diagnosis Clinical Research Groups (CSGs) of the National Cancer Research Institute (NCRI), and received positive feedback but with reservations. These reservations I have taken on board and have been working hard to modify during the past 2 years. In March 2016, work initiated as preparation for this research led our team to win “Best Public and Patient Involvement Award” in the Bristol Post Health and Care Awards 2016. In June 2016, at the National Institute of Health Research (NIHR) Grant Writing Retreat, our research team won the “Research likely to lead to the greatest patient benefit” prize. For the past year I have been working closely with Dr. Sian Taylor-Philip and Professor Janet Dunn of Warwick Clinical Trials Unit to take this research forward. Thank you for inviting me to talk about where we are now in the development of this research and particularly about our: “Development of a Teaching Tool for FAST MRI in Preparation for a Multicentre Study”.
Consultant Breast Surgeon at the Royal Derby Hospital
President of the Association of Breast Surgery (ABS)
National Advisor to Public Health England on Breast Screening
Chair of the Breast Screening Research Advisory Committee
Previous Chair of the ABS / NHSBSP Screening Audit 2013-16
Consultant Radiologist, Cambridge Breast Unit since November 2007.
Director of Screening July 2010 – Sept 2014.
Before that, he was the director of Warwickshire, Solihull & Coventry Breast Screening Programme for 19 years.
Past President European Society of Breast Imaging 2010 – 2013
Clinical imaging lead (Breast) at the Cambridge Biomedical Research Centre and the Experimental Cancer Medicine Unit:
Monitoring and predicting breast tumour response in phase 1 and 2 trials.
Optimising existing and evaluating new imaging techniques for the breast and axilla.
His other research interest is anything and every thing affecting radiological and surgical performance in breast screening and using data to improve performance. In particular related to non operative diagnosis, staging of the breast and the diagnosis and management of DCIS.
Chief Investigator LORIS
Prof. Michaela Higgins has been a Consultant Medical Oncologist at the Mater Misericordiae University Hospital since 2015, with specialty interest in breast and lung cancers. Previous to this she was an Assistant Professor of Medicine at Harvard Medical School and an Attending (Consultant) Physician at Massachusetts General Hospital, Boston. Her cancer research has been awarded competitive funding by the U.S. Department of Defense, The Conquer Cancer Foundation and the Avon Foundation. Prof. Higgins has led numerous national and international clinical trials for patients with cancer. Her research has been awarded multiple competitive grants and she has over 50 manuscripts in peer-reviewed journals. Prof. Higgins is a member of Cancer Research UK’s Clinical Trials Awards and Advisory Committee and the Mater Hospital Lung Cancer Working Group. She serves on the University College Dublin Clinical Research Centre Executive Committee.
I am a Director of Breast Screening for Leeds/Wakefield and Secretary of the BSBR. I also sit on the audit committee for the breast screening surgical audit meeting. I have played an active role in trying to develop guidelines for managing B3 lesions with vacuum assisted excision. I believe in evidence based practice and have shown that this is an effective alternative to surgery in our own practice. In developing national guidance we will be able to provide robust data for the future which will enable us to improve the pathway and gain more insight regarding follow up of these indeterminate lesions.
Olive has worked in the field of breast screening quality assurance for over 17 years. She is currently the head of QA for Midlands & East and is also the national lead for breast screening QA.
Dr. Bleicher is a surgical oncologist whose subspecialty is breast cancer and breast disease. He is the Director of the Society of Surgical Oncology-approved breast fellowship program at the Fox Chase Cancer Center in Philadelphia, PA, one of only 45 such programs in the United States that trains surgeons to become breast surgeons. He has been on faculty since 2006 and Dr. Bleicher is the Leader of the Breast Service Line (breast cancer clinical program) at Fox Chase Cancer Center where he is a Professor of Surgical Oncology. He has been involved with the National Accreditation Program for Breast Centers, the primary accrediting body for breast centers around the U.S. since 2007 and is now sits on its Board of Directors. He is also a Vice-Chair of its Information Technology and Quality Improvement Committee, and is a Surveyor who accredits breast centers around the country as well.
He has been heavily involved in academic committees and organizations such as the Society of Surgical Oncology. Dr. Bleicher’s areas of clinical research in breast cancer have included breast imaging, surgical treatment, decision making, evaluation-associated delays, and health services research, via national datasets including SEER-Medicare and the National Cancer Database. He has 68 publications in total, including peer reviewed and invited manuscripts, and he has written 7 book chapters. He has been interviewed and/or quoted by the lay press and medical media in the United States nearly 100 times to date.
Dr. Bleicher graduated from Temple University School of Medicine in Philadelphia, and completed a General Surgical residency at the Mercy Hospital of Pittsburgh. He completed a Surgical Oncology Fellowship at the John Wayne Cancer Institute in Santa Monica, CA. Dr. Bleicher was born in and resides in Philadelphia.
Rosalind Given-Wilson is a Consultant Radiologist at St Georges Healthcare NHS Trust.
She set up the South West London breast screening service in 1991 and was Director of Screening, then Medical Director until 2015. She is also a Non executive director at Moorfields Eye Hospital.
She has research interests in the optimisation of breast imaging and decision making having published over 120 papers and abstracts. She is involved with national QA of breast screening sitting on the DH advisory committee on breast cancer screening. She ran the St Georges National breast screening training centre providing post graduate training and has held the Royal College of Radiologists Breast imaging Professorship, this involved lecturing widely nationally and internationally on breast imaging. She has been involved with PHE work on implementing Duty of candour in breast screening.